International Medical Center of Biomaterials Processing and Cryostorage (MOEX:GEMA)

MOEX:GEMA Cash Flow Statement

Financials in millions RUB. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Net Income	151.14	151.22	125.78	98.17	129.17	122.77
Depreciation & Amortization	15.28	13.61	11.24	6.86	4.14	10.41
Other Amortization	0.09	0.09	-	-	-	-
Other Operating Activities	89.41	82.69	86.76	136.07	111.19	4.69
Change in Accounts Receivable	-	-	-	-	-	-11.99
Change in Inventory	-	-	-	-	-	-1.07
Change in Accounts Payable	-	-	-	-	-	19.2
Operating Cash Flow	255.91	247.6	223.77	241.11	244.51	134.72
Operating Cash Flow Growth	-	10.65%	-7.19%	-1.39%	81.49%	19.07%
Capital Expenditures	-9.63	-10.59	-14.18	-9.27	-4.68	-2.46
Investment in Securities	-0.49	-0.49	5.5	-99	-506.4	-
Other Investing Activities	29.38	21.94	6.54	0.89	32.19	1.17
Investing Cash Flow	-170.75	-6.53	4.84	-252.87	-77.52	-54.92
Long-Term Debt Issued	-	-	-	200	-	-
Total Debt Issued	-	-	-	200	-	-
Long-Term Debt Repaid	-	-	-	-1.87	-	-
Net Debt Issued (Repaid)	-	-	-	198.13	-	-
Common Dividends Paid	-150.74	-153.4	-122.74	-141.06	-150.19	-85.1
Other Financing Activities	-8.7	-6.88	14.25	-5	-6.02	-4.04
Financing Cash Flow	-159.44	-160.28	-108.49	52.07	-156.21	-89.14
Foreign Exchange Rate Adjustments	-	0.03	-0.03	-0.3	-0.01	-0.09
Net Cash Flow	-74.28	80.83	120.09	40.01	10.76	-9.43
Free Cash Flow	246.28	237.02	209.59	231.83	239.82	132.26
Free Cash Flow Growth	-	13.08%	-9.59%	-3.33%	81.33%	16.90%
Free Cash Flow Margin	66.98%	67.99%	73.93%	91.03%	90.20%	54.51%
Free Cash Flow Per Share	16.50	15.88	14.04	15.53	16.06	8.86
Cash Interest Paid	31.57	31.57	31.57	3.74	3.52	4.04
Levered Free Cash Flow	141.2	108.53	99.84	557.78	-334.44	95.29
Unlevered Free Cash Flow	162.93	130.14	120.82	568.79	-332.25	99.57
Change in Working Capital	-	-	-	-	-	6.14

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.